
Complex small molecules reshape drug R&D, demanding integrated discovery to manufacturing solutions.
WuXi AppTec highlights how the increasing structural complexity of small molecules, such as targeted protein degraders and covalent inhibitors, is transforming drug research and development. These new molecules require advanced, integrated approaches...

